Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,052 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size.
Hansen KW, Kaiser C, Hvelplund A, Soerensen R, Madsen JK, Jensen JS, Pedersen SH, Eberli FR, Erne P, Alber H, Pfisterer M, Galatius S; BASKET PROVE Investigators. Hansen KW, et al. Among authors: kaiser c. Int J Cardiol. 2013 Oct 25;169(1):29-34. doi: 10.1016/j.ijcard.2013.08.091. Epub 2013 Sep 8. Int J Cardiol. 2013. PMID: 24063913 Clinical Trial.
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design.
Jeger R, Pfisterer M, Alber H, Eberli F, Galatius S, Naber C, Pedrazzini G, Rickli H, Jensen JS, Vuilliomenet A, Gilgen N, Kaiser C. Jeger R, et al. Among authors: kaiser c. Am Heart J. 2012 Feb;163(2):136-41.e1. doi: 10.1016/j.ahj.2011.08.023. Am Heart J. 2012. PMID: 22305828 Clinical Trial.
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease.
Wanitschek M, Pfisterer M, Hvelplund A, De Servi S, Bertel O, Jeger R, Rickenbacher P, Iversen A, Jensen JS, Galatius S, Kaiser C, Alber H; BASKET-PROVE Investigators. Wanitschek M, et al. Among authors: kaiser c. Int J Cardiol. 2013 Oct 3;168(3):2381-8. doi: 10.1016/j.ijcard.2013.01.257. Epub 2013 Feb 27. Int J Cardiol. 2013. PMID: 23453439 Clinical Trial.
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial.
Jensen MT, Kaiser C, Sandsten KE, Alber H, Wanitschek M, Iversen A, Jensen JS, Pedersen S, Soerensen R, Rickli H, Zurek M, Fahrni G, Bertel O, De Servi S, Erne P, Pfisterer M, Galatius S; BASKET-PROVE investigators. Jensen MT, et al. Among authors: kaiser c. Int J Cardiol. 2013 Oct 9;168(4):3802-6. doi: 10.1016/j.ijcard.2013.06.034. Epub 2013 Jul 11. Int J Cardiol. 2013. PMID: 23849965 Clinical Trial.
Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial.
Pedersen SH, Pfisterer M, Kaiser C, Jensen JS, Alber H, Rickenbacher P, Sørensen R, Iversen A, Jensen MT, Wadt K, Galatius S; BASKET-PROVE Investigators. Pedersen SH, et al. Among authors: kaiser c. EuroIntervention. 2014 May;10(1):58-64. doi: 10.4244/EIJV10I1A11. EuroIntervention. 2014. PMID: 24694667 Free article. Clinical Trial.
Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial.
Kurz DJ, Bernheim AM, Tüller D, Zbinden R, Jeger R, Kaiser C, Galatius S, Hansen KW, Alber H, Pfisterer M, Eberli FR. Kurz DJ, et al. Among authors: kaiser c. Am Heart J. 2015 Oct;170(4):787-795.e1. doi: 10.1016/j.ahj.2015.07.009. Epub 2015 Jul 17. Am Heart J. 2015. PMID: 26386803 Clinical Trial.
Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
Zbinden R, von Felten S, Wein B, Tueller D, Kurz DJ, Reho I, Galatius S, Alber H, Conen D, Pfisterer M, Kaiser C, Eberli FR. Zbinden R, et al. Among authors: kaiser c. Cardiovasc Ther. 2017 Feb;35(1):19-25. doi: 10.1111/1755-5922.12229. Cardiovasc Ther. 2017. PMID: 27662632 Free article.
Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials).
Jatene T, Biering-Sørensen T, Nochioka K, Mangione FM, Hansen KW, Sørensen R, Jensen JS, Jørgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators. Jatene T, et al. Among authors: kaiser c. Am J Cardiol. 2017 Jan 1;119(1):14-19. doi: 10.1016/j.amjcard.2016.09.013. Epub 2016 Sep 29. Am J Cardiol. 2017. PMID: 27788931 Clinical Trial.
Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials.
Mangione FM, Biering-Sørensen T, Nochioka K, Jatene T, Silvestre OM, Hansen KW, Sørensen R, Jensen JS, Jorgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S. Mangione FM, et al. Among authors: kaiser c. Catheter Cardiovasc Interv. 2018 Apr 1;91(5):867-873. doi: 10.1002/ccd.27200. Epub 2017 Jul 19. Catheter Cardiovasc Interv. 2018. PMID: 28722266
1,052 results